Adagio Therapeutics Inc
NASDAQ:ADGI
Income Statement
Earnings Waterfall
Adagio Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-230.7m
USD
|
Operating Income
|
-230.7m
USD
|
Other Expenses
|
-10.7m
USD
|
Net Income
|
-241.3m
USD
|
Income Statement
Adagio Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||
Operating Expenses |
(65)
|
(227)
|
(231)
|
|
Selling, General & Administrative |
(3)
|
(37)
|
(47)
|
|
Research & Development |
(62)
|
(190)
|
(184)
|
|
Operating Income |
(65)
N/A
|
(227)
-247%
|
(231)
-2%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
0
|
2
|
4
|
|
Total Other Income |
0
|
(2)
|
(15)
|
|
Pre-Tax Income |
(65)
N/A
|
(227)
-247%
|
(241)
-6%
|
|
Net Income | ||||
Income from Continuing Operations |
(65)
|
(227)
|
(241)
|
|
Net Income (Common) |
(65)
N/A
|
(227)
-247%
|
(241)
-6%
|
|
EPS (Diluted) |
-0.6
N/A
|
-5.32
-787%
|
-2.23
+58%
|